Navigation Links
Derma Sciences Reports Fourth Quarter, Year-End Results for 2008
Date:4/1/2009

rom the University of Southern California in Q4 of 2007. Patient enrollment for a Phase II study began in Q4 of 2008. Results from this study are expected to be submitted to the FDA in Q2 of 2010.

For more information about Derma Sciences, Inc., visit http://www.dermasciences.com.

Forward-looking Statements

Statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements which may be made in this release or which are otherwise made by or on behalf of the Company. Factors which may affect the Company's results include, but are not limited to, product demand, market acceptance, impact of competitive products and prices, product development, completion of an acquisition, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements Include but are not limited to, those discussed in the Company's filings with the Securities and Exchange Commission.

    Contact:

    Derma Sciences, Inc.
    Edward J. Quilty
    Chairman and CEO
    equilty@dermasciences.com
    (609) 514-4744

    Allen & Caron Inc
    Rudy Barrio (US Investors)
    '/>"/>
SOURCE Derma Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Derma Sciences to Report 2008 Fourth Quarter and Year-End Results on April 1, 2009
2. Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced
3. Wendy E. Roberts, MD, Named 2009-2010 President of the Womens Dermatologic Society
4. Teikoku Pharma USA and Eisai Co., Ltd. Announce Licensing Agreement for a New 7-Day Transdermal Formulation of Donepezil.
5. Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting
6. Aesthera Announces Breakthrough Innovations at 2009 American Academy of Dermatology (AAD) Meeting
7. The Texas Institute of Dermatology Team Finds Easy-to-Apply, Topical Drug Just as Good as Injectable Compound for a Disfigurating Skin Infection
8. NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting
9. Professional Skin Care Company OrthoNeutrogena Becomes Ortho Dermatologics
10. American Academy of Dermatology Issues New Guidelines For The Management of Psoriasis With Topical Therapies
11. Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 70 and over who identify themselves as ,old, feel ... perceive they have lower value than younger age groups. ... Kent, titled ,Being old and ill, across different countries: ... used data from the European Social Survey. Respondents, who ... self-rate their health., The researchers found that those living ...
(Date:8/28/2014)... out how to safely increase the radiotherapy dose given ... control and survival. , Standard treatment for locally advanced ... and chemotherapy. Traditionally this is planned in a one-size-fits-all ... enough to stop tumour growth. , The potential to ... between patients and depends on the size and location ...
(Date:8/28/2014)... Vaccine market - the once low-profit ... other healthcare industry sectors and sub-circles in the U.S. ... with respect to evolving and spreading infectious diseases. This ... improved understanding for a well-balanced life and improved immune ... led to new opportunities for manufacturing novel preventive and ...
(Date:8/28/2014)... Minneapolis, Minn. (PRWEB) August 28, 2014 ... in North America, today announced the launch of its ... business with AmeriPride even easier and more convenient for ... account information online and better communicate with the company. ... ability to:, Access, download and ...
(Date:8/28/2014)... 2014 After more than two years ... is excited to announce the opening of Houston’s Mirror ... any city, Mirror Mirror Beauty Boutique offers premium aesthetic ... the corner of Richmond and Drexel near Highland Village, ... and cutting-edge technology in a private, easy to access ...
Breaking Medicine News(10 mins):Health News:Research demonstrates potential method to better control lung cancer using radiotherapy 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 3Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3Health News:Mirror Mirror Beauty Boutique to Welcome Its First Patients 2
... for the first time that human embryonic stem cells ... mature T-cells//, raising hopes for a gene therapy to ... and the Institute for Stem Cell Biology and Medicine ... embryonic stem cells into blood-forming stem cells that in ...
... recent survey it was found that international nurses would need to ... NHS//. ,The step was mainly taken to give jobs ... nurses come to Britain from outside the European Union every year. ... the Philippines and Australia. The rule applies to nurses in bands ...
... 45 seconds, another American has a stroke, caused either by a ... minutes//, one of them will die. ,That's the bad news. ... to find and fix the problems that cause many strokes — ... ever having to open up the skull. ,New technologies, ...
... Dr. Bing-Huei Chen and colleagues it was found that ... form during cooking. ,The research was conduced ... Products (COPs) is produced when cholesterol-rich foods are processed ... the body cells leading to heart disease or cancer. ...
... California Supreme Court said that partners must inform their spouse about ... ,This came down as the court ruling in San Francisco when ... court. The wife accused the ex-husband of transmitting AIDS to her. ... decided that the spouse or partner of a person who has ...
... from the Korea Research Institute of Bioscience and Biotechnology//. ... found a human gene that aids in the growth and spread ... about the discovery and said that it would help in the ... was mainly conducted on mice and the research team found that ...
Cached Medicine News:Health News:T-cells Developed from Human Embryonic Stem Cells 2Health News:Brain Surgery Without the Surgery? 2Health News:Brain Surgery Without the Surgery? 3Health News:Brain Surgery Without the Surgery? 4Health News:Brain Surgery Without the Surgery? 5Health News:Brain Surgery Without the Surgery? 6
(Date:8/28/2014)... , Kalifornien, 28. August 2014 /PRNewswire/ ... den Start der Patientenrekrutierung für eine ... Forschungsausnahmegenehmigung) zur Beurteilung der Sicherheit und ... von Aneurysmen („WEB") bekanntgegeben. Adam Arthur, MD, ... Department of Neurosurgery/Semmes-Murphey Clinic, und Hauptprüfarzt ...
(Date:8/28/2014)... N.Y. , Aug. 28, 2014 ... have entered a partnership to advance an experimental ... myeloma (SMM), an asymptomatic stage of myeloma. ... Program® (TAP), through which LLS forges collaborations with ... faster. OncoPep is developing a ...
(Date:8/28/2014)... Aug. 28, 2014  STAAR Surgical Company (NASDAQ: ... lenses and delivery systems for the eye, today announced that ... at the New York Palace Hotel on Wednesday, September 3 ... Caldwell , President and CEO will offer a general overview ... developments and be joined by Steve Brown , CFO, ...
Breaking Medicine Technology:Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 2Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 3The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine 2STAAR Surgical To Present At The Baird 2014 Health Care Conference 2
... Pharma Inc. (Tokyo:4503, "Astellas") announced today that it is ... which will further reinforce the company,s commitment to corporate social ... "We are committed to adopting the Global Compact and ... day-to-day operations of our company and through Astellas, annual ...
... CITY, Nov. 10, 2011 Dynatronics Corporation (NASDAQ: ... ended September 30, 2011 during the morning of Monday, November ... call for investors later that day at 1:30 p.m. ET ... interested in participating should call (800) 926-5230 and use access ...
Cached Medicine Technology:Astellas Signs United Nations Global Compact 2Astellas Signs United Nations Global Compact 3
... The design of the Hi-Top ... to be held back in ... shoe counter. The front is ... and compression on the toes. ...
... semi-rigid post op shoe is ideal for ... breathable upper will keep your patient both ... closure provides even tension and compression. The ... support for your patient. The black TPR ...
Comfortably positions the affected foot at 90 to provide continuous and effective stretching of the plantar fascia and Achilles Tendon...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
Medicine Products: